DARYL GAUGLER - 31 Dec 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Operating Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
31 Dec 2024
Transactions value $
$3,900
Form type
4
Filing time
06 Jan 2025, 18:22:59 UTC
Previous filing
16 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Award $3,900 +244 +0.21% $16.01 115,443 31 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2024.